• Helping you understand who owns the world, and how you can invest in it.
  • Follow us

Cabaletta Bio, Inc.

Cabaletta Bio, Inc.

Public
CABA
United States
SectorHealthcare
CountryUnited States
Market cap351.78M
A clinical-stage biopharmaceutical company developing engineered T-cell therapies for autoimmune diseases.

Where to buy Cabaletta Bio, Inc. (CABA)

CABA trades on these platforms. Substox may earn a commission if you open an account through one of these links, at no cost to you. It never changes what the data on this page says. Substox is not a licensed financial adviser and this is not investment advice.

Similar public companies in Healthcare